• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Intern Med . A Comparison of Clinical Presentations in Coronavirus Disease 2019 Caused by Different Omicron variants in Japan: A Retrospective Stud

tetano

Editor, Senior Moderator
Intern Med


. 2023 May 24.
doi: 10.2169/internalmedicine.1399-22. Online ahead of print. A Comparison of Clinical Presentations in Coronavirus Disease 2019 Caused by Different Omicron variants in Japan: A Retrospective Study

Ryutaro Hirama[SUP] 1 [/SUP], Kenichiro Takeda[SUP] 1 [/SUP], Seiichiro Sakao[SUP] 1 [/SUP], Hajime Kasai[SUP] 1 2 3 [/SUP], Shizu Miyata[SUP] 1 [/SUP], Kohei Shikano[SUP] 1 [/SUP], Akira Naito[SUP] 1 [/SUP], Mitsuhiro Abe[SUP] 1 [/SUP], Takeshi Kawasaki[SUP] 1 [/SUP], Ayako Shigeta[SUP] 1 [/SUP], Taka-Aki Nakada[SUP] 4 [/SUP], Hidetoshi Igari[SUP] 5 [/SUP], Takuji Suzuki[SUP] 1 [/SUP]



Affiliations
Abstract

Objective We evaluated the clinical differences in coronavirus disease 2019 (COVID-19) patients between the sixth wave with the Omicron BA.1/BA.2 dominant variant (from January to April 2022) and seventh wave with the Omicron BA.5 dominant variant (from July to August 2022). Methods This retrospective, single-center, observational study included COVID-19 patients admitted to our institution in the sixth wave (sixth-wave group) and the seventh wave (seventh-wave group). Inter-group comparisons of clinical presentations, the prognosis, and proportion of nosocomial infections were performed. Results A total of 190 patients were included (93 and 97 patients in the sixth- and seventh-wave groups, respectively). While there were no significant differences in severity, significantly more patients developed pneumonia caused by COVID-19 in the sixth-wave group than in the seventh-wave group. Although there was no marked difference in in-hospital deaths, more patients died from COVID-19 in the sixth-wave group than in the seventh-wave group. There were significantly more COVID-19 inpatients with nosocomial infections in the seventh-wave group than in the sixth-wave group. Pneumonia from COVID-19 was significantly more severe in the sixth-wave group than in the seventh-wave group. Conclusions COVID-19 patients in the seventh wave are at a lower risk of pneumonia than those in the sixth wave. However, even in the seventh wave, patients with underlying diseases have a risk of death because of the exacerbation of underlying diseases triggered by COVID-19.

Keywords: coronavirus disease 2019; nosocomial infection; omicron variant; pneumonia.

 
Back
Top Bottom